Thiamine deficiency: A model of metabolic encephalopathy and of selective neuronal vulnerability

Metabolic Encephalopathy

Volumn , Issue , 2009, Pages 235-260

  Karuppagounder, Saravanan ^a   Gibson, Gary E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053647121     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-79112-8_12     Document Type: Chapter

References (92)

1. Alcaide, M. L., et al., 2003. Wernicke's encephalopathy in AIDS: a preventable cause of fatal neurological deficit. Int J STD AIDS. 14, 712-713.
2. Alves, L. F., et al., 2006. [Beriberi after bariatric surgery: not an unusual complication. Report of two cases and literature review]. Arq Bras Endocrinol Metabol. 50, 564-568.
3. Andreassen, O. A., et al., 2001. Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease. Ann Neurol. 50, 112-117.
4. Balaghi, M., Pearson, W. N., 1966. Tissue and intracellular distribution of radioactive thiamine in normal and thiamine-deficient rats. J Nutr. 89, 127-132.
5. Barclay, L. L., Gibson, G. E., 1982. Spontaneous open-field behavior in thiamin-deficient rats. J Nutr. 112, 1899-1905.
6. Barclay, L. L., et al., 1981a. Impairment of behavior and acetylcholine metabolism in thiamine deficiency. J Pharmacol Exp Ther. 217, 537-543.
7. Barclay, L. L., et al., 1981b. The string test: an early behavioral change in thiamine deficiency. Pharmacol Biochem Behav. 14, 153-157.
8. Barclay, L. L., et al., 1982. Cholinergic therapy of abnormal open-field behavior in thiamin-deficient rats. J Nutr. 112, 1906-1913.
9. Blass, J. P., Gibson, G. E., 1977. Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff syndrome. N Engl J Med. 297, 1367-1370.
10. Blass, J. P., Gibson, G. E., 1979. Genetic factors in Wernicke-Korsakoff syndrome. Alcohol Clin Exp Res. 3, 126-134.
11. Blass, J. P., et al., 1975. Clinical and metabolic abnormalities accompanying deficiencies in pyruvate oxidation. F. A. Hommes (ed.) Academic Press, New York, pp. 193
12. Bubber, P., et al., 2005. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol. 57, 695-703.
13. Bublitz, C., Steavenson, S., 1988. The pentose phosphate pathway in the endoplasmic reticulum. J Biol Chem. 263, 12849-12853.
14. Butterworth, R. F., et al., 1993. Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke-Korsakoff syndrome. Alcohol Clin Exp Res. 17, 1084-1088.
15. Calingasan, N. Y., Gibson, G. E., 2000a. Dietary restriction attenuates the neuronal loss, induction of heme oxygenase-1 and blood-brain barrier breakdown induced by impaired oxidative metabolism. Brain Res. 885, 62-69.
16. Calingasan, N. Y., Gibson, G. E., 2000b. Vascular endothelium is a site of free radical production and inflammation in areas of neuronal loss in thiamine-deficient brain. Ann N Y Acad Sci. 903, 353-356.
17. Calingasan, N. Y., et al., 1994a. Distribution of the alpha-ketoglutarate dehydrogenase complex in rat brain. J Comp Neurol. 346, 461-479.
18. Calingasan, N. Y., et al., 1994b. Selective enrichment of cholinergic neurons with the alphaketoglutarate dehydrogenase complex in rat brain. Neurosci Lett. 168, 209-212.
19. Calingasan, N. Y., et al., 1995a. Blood-brain barrier abnormalities in vulnerable brain regions during thiamine deficiency. Exp Neurol. 134, 64-72.
20. Calingasan, N. Y., et al., 1995b. Accumulation of amyloid precursor protein-like immunoreactivity in rat brain in response to thiamine deficiency. Brain Res. 677, 50-60.
21. Calingasan, N. Y., et al., 1995c. Heterogeneous expression of transketolase in rat brain. J Neurochem. 64, 1034-1044.
22. Calingasan, N. Y., et al., 1996. Novel neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency. Am J Pathol. 149, 1063-1071.
23. Calingasan, N. Y., et al., 1998. Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism. Am J Pathol. 153, 599-610.
24. Calingasan, N. Y., et al., 1999. Oxidative stress is associated with region-specific neuronal death during thiamine deficiency. J Neuropathol Exp Neurol. 58, 946-958.
25. Calingasan, N. Y., et al., 2000. Vascular factors are critical in selective neuronal loss in an animal model of impaired oxidative metabolism. J Neuropathol Exp Neurol. 59, 207-217.
26. Coy, J. F., et al., 2005. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab. 51, 257-273.
27. Desjardins, P., Butterworth, R. F., 2005. Role of mitochondrial dysfunction and oxidative stress in the pathogenesis of selective neuronal loss in Wernicke's encephalopathy. Mol Neurobiol. 31, 17-25.
28. Falk, R. E., et al., 1976. Ketonic diet in the management of pyruvate dehydrogenase deficiency. Pediatrics. 58, 713-721.
29. Foldi, M., et al., 2007. Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer. Oncol Rep. 17, 841-845.
30. Freeman, G. B., et al., 1987. Effect of age on behavioral and enzymatic changes during thiamin deficiency. Neurobiol Aging. 8, 429-434.
31. Gibson, G. E., Blass, J. P., 1976. Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycemia. J Neurochem. 27, 37-42.
32. Gibson, G. E., Blass, J. P., 2007. Thiamine-dependent processes and treatment strategies in neurodegeneration. Antioxid Redox Signal. 9, 1605-1619.
33. Gibson, G. E., et al., 1975. Decreased synthesis of acetylcholine accompanying impaired oxidation of pyruvic acid in rat brain minces. Biochem J. 148, 17-23.
34. Gibson, G. E., et al., 1983. Cholinergic drugs and 4-aminopyridine alter hypoxic-induced behavioral deficits. Pharmacol Biochem Behav. 18, 909-916.
35. Gibson, G. E., et al., 1984. Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal. Neurochem Res. 9, 803-814.
36. Gibson, G. E., et al., 1988. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol. 45, 836-840.
37. Gibson, G., et al., 1989. Regionally selective alterations in enzymatic activities and metabolic fluxes during thiamin deficiency. Neurochem Res. 14, 17-24.
38. Gibson, G. E., et al., 1999. Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits. Ann N Y Acad Sci. 893, 79-94.
39. Gibson, G. E., et al., 2003. Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson's disease. Neurochem Int. 43, 129-135.
40. Hammes, H. P., et al., 2003. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med. 9, 294-299.
41. Hazell, A. S., Wang, C., 2005. Downregulation of complexin I and complexin II in the medial thalamus is blocked by N-acetylcysteine in experimental Wernicke's encephalopathy. J Neurosci Res. 79, 200-207.
42. Hazell, A. S., et al., 1993. Cerebral vulnerability is associated with selective increase in extracellular glutamate concentration in experimental thiamine deficiency. J Neurochem. 61, 1155-1158.
43. Hazell, A. S., et al., 2003. Thiamine deficiency results in downregulation of the GLAST glutamate transporter in cultured astrocytes. Glia. 43, 175-184.
44. Heroux, M., et al., 1996. Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer's disease. Metab Brain Dis. 11, 81-88.
45. Huang, H. M., et al., 2003. Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, and necrotic cell death. J Neurosci Res. 74, 309-317.
46. Huang, H. M., et al., 2005. Selective antioxidants differentially modify endoplasmic reticulum Ca2+ stores and capacitative calcium entry. Soc Neurosci. 35, 93-100.
47. Jeitner, T. M., et al., 2005. Inhibition of the alpha-ketoglutarate dehydrogenase complex by the myeloperoxidase products, hypochlorous acid and mono-N-chloramine. J Neurochem. 92, 302-310.
48. Jimenez-Jimenez, F. J., et al., 1999. Cerebrospinal fluid levels of thiamine in patients with Parkinson's disease. Neurosci Lett. 271, 33-36.
49. Karachalias, N., et al., 2005. High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats. Ann N Y Acad Sci. 1043, 777-783.
50. Kark, R. A., et al., 1975. Experimental thiamine deficiency. Neuropathic and mitochondrial changes induced in rat muscle. Arch Neurol. 32, 818-825.
51. Karuppagounder, S. S., et al., 2006. Mild impairment of oxidative metabolism exacerbates pathology in a transgenic model of plaque formation. Soc Neurosci. 36, 170-715.
52. Karuppagounder, S. S., et al., 2007. Changes in inflammatory processes associated with selective vulnerability following mild impairment of oxidative metabolism. Neurobiol Dis. 26, 353-362.
53. Karuppagounder, S. S., et al., 2008. Translocation of Amyloid Precursor Protein C-terminal Fragment (s) to the Nucleus Precedes Neuronal Death due to Thiamine Deficiency-induced Mild Impairment of Oxidative Metabolism. Neurochemical research, 33, 1365-1372.
54. Ke, Z. J., Gibson, G. E., 2004. Selective response of various brain cell types during neurodegeneration induced by mild impairment of oxidative metabolism. Neurochem Int. 45, 361-369.
55. Ke, Z. J., et al., 2003. Reversal of thiamine deficiency-induced neurodegeneration. J Neuropathol Exp Neurol. 62, 195-207.
56. Ke, Z. J., et al., 2005a. CD40-CD40L interactions promote neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism. Neurochem Int. 47, 204-215.
57. Ke, Z. J., et al., 2005b. CD40L deletion delays neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism. J Neuroimmunol. 164, 85-92.
58. Ke, Z. J., et al., 2006. Peripheral inflammatory mechanisms modulate microglial activation in response to mild impairment of oxidative metabolism. Neurochem Int. 49, 548-556.
59. Klivenyi, P., et al., 2004. Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity. J Neurochem. 88, 1352-1360.
60. Langlais, P. J., Mair, R. G., 1990. Protective effects of the glutamate antagonist MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain. J Neurosci. 10, 1664-1674.
61. Langlais, P. J., Savage, L. M., 1995. Thiamine deficiency in rats produces cognitive and memory deficits on spatial tasks that correlate with tissue loss in diencephalon, cortex and white matter. Behav Brain Res. 68, 75-89.
62. Lee, B. Y., et al., 2005. Thiamin deficiency: a possible major cause of some tumors? (review). Oncol Rep. 14, 1589-1592.
63. Martin, E., et al., 2005. Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress. J Neurosci Res. 79, 240-247.
64. Mastrogiacomo, F., Kish, S. J., 1994. Cerebellar alpha-ketoglutarate dehydrogenase activity is reduced in spinocerebellar ataxia type 1. Ann Neurol. 35, 624-626.
65. McLure, K. G., et al., 2004. NAD+ modulates p53 DNA binding specificity and function. Mol Cell Biol. 24, 9958-9967.
66. McRee, R. C., et al., 2000. Increased histamine release and granulocytes within the thalamus of a rat model of Wernicke's encephalopathy. Brain Res. 858, 227-236.
67. Meng, J. S., Okeda, R., 2003. Neuropathological study of the role of mast cells and histaminepositive neurons in selective vulnerability of the thalamus and inferior colliculus in thiaminedeficient encephalopathy. Neuropathology. 23, 25-35.
68. Nakagawasai, O., et al., 2000a. Immunohistochemical estimation of brain choline acetyltransferase and somatostatin related to the impairment of avoidance learning induced by thiamine deficiency. Brain Res Bull. 52, 189-196.
69. Nakagawasai, O., et al., 2000b. Immunohistochemical estimation of rat brain somatostatin on avoidance learning impairment induced by thiamine deficiency. Brain Res Bull. 51, 47-55.
70. Neufeld, E. J., et al., 2001. Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport. Blood Cells Mol Dis. 27, 135-138.
71. Pannunzio, P., et al., 2000. Thiamine deficiency results in metabolic acidosis and energy failure in cerebellar granule cells: an in vitro model for the study of cell death mechanisms in Wernicke's encephalopathy. J Neurosci Res. 62, 286-292.
72. Park, L. C., et al., 2000. Metabolic impairment elicits brain cell type-selective changes in oxidative stress and cell death in culture. J Neurochem. 74, 114-124.
73. Park, L. C., et al., 2001a. Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy. J Neurosci Res. 66, 1028-1034.
74. Park, L. C., et al., 2001b. Co-culture with astrocytes or microglia protects metabolically impaired neurons. Mech Ageing Dev. 123, 21-27.
75. Pawlik, F., et al., 1977. Peripheral nerve changes in thiamine deficiency and starvation. Acta Neuropathologica. 39, 211-218.
76. Roland, J. J., Savage, L. M., 2007. Blunted hippocampal, but not striatal, acetylcholine efflux parallels learning impairment in diencephalic-lesioned rats. Neurobiol Learn Mem. 87, 123-132.
77. Savage, L. M., et al., 2007. Selective septohippocampal - but not forebrain amygdalar - cholinergic dysfunction in diencephalic amnesia. Brain Res. 1139, 210-219.
78. Sheline, C. T., Wei, L., 2006. Free radical-mediated neurotoxicity may be caused by inhibition of mitochondrial dehydrogenases in vitro and in vivo. Neuroscience. 140, 235-246.
79. Sheline, C. T., et al., 2002. Cofactors of mitochondrial enzymes attenuate copper-induced death in vitro and in vivo. Ann Neurol. 52, 195-204.
80. Sheu, K. F., et al., 1996. Regional reductions of transketolase in thiamine-deficient rat brain. J Neurochem. 67, 684-691.
81. Shi, Q., et al., 2007. Responses of the mitochondrial alpha-ketoglutarate dehydrogenase complex to thiamine deficiency may contribute to regional selective vulnerability. Neurochem Int. 50, 921-931.
82. Shin, B. H., et al., 2004. Thiamine attenuates hypoxia-induced cell death in cultured neonatal rat cardiomyocytes. Mol Cells. 18, 133-140.
83. Shneider, A. B., 1991. [Anti-ischemic heart protection using thiamine and nicotinamide]. Patol Fiziol Eksp Ter. 9-10.
84. Starkov, A. A., et al., 2004. Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J Neurosci. 24, 7779-2788.
85. Todd, K. G., Butterworth, R. F., 1999. Early microglial response in experimental thiamine deficiency: an immunohistochemical analysis. Glia. 25, 190-198.
86. Ueda, K., et al., 2006. Severe thiamine deficiency resulted in Wernicke's encephalopathy in a chronic dialysis patient. Clin Exp Nephrol. 10, 290-293.
87. Victor, M., et al., 1971. The Wernicke-Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post-mortem examinations. Contemp Neurol Ser. 7, 1-206.
88. Wang, C., et al., 2007a. Effect of ascorbic acid and thiamine supplementation at different concentrations on lead toxicity in liver. Ann Occup Hyg. 51, 563-569.
89. Wang, X., et al., 2007b. Activation of double-stranded RNA-activated protein kinase by mild impairment of oxidative metabolism in neurons. J Neurochem. 103, 2380-2390.
90. Wang, X., et al., 2007c. Thiamine deficiency induces endoplasmic reticulum stress in neurons. Neuroscience. 144, 1045-1056.
91. Yates, C. M., et al., 1990. Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J Neurochem. 55, 1624-1630.
92. Zhao, N., et al., 2007. Impaired hippocampal neurogenesis is involved in cognitive dysfunction induced by thiamine deficiency at early pre-pathological lesion stage. Neurobiol Dis. 29, 176-185.